Evidence map›Paper›PMID 31696436›Full record

ArticleThe patient2019

Advancing the Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation: A Summary Report of the Patient Preference Workshop.

Heather L Benz, Ting-Hsuan Joyce Lee, Jui-Hua Tsai, John F P Bridges, Sara Eggers, Megan Moncur, Fadia T Shaya, Ira Shoulson, Erica S Spatz, Leslie Wilson and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in The patient, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Quantifying patient preferences for treatments for refractory chronic spontaneous urticaria.The journal of allergy and clinical immunology. Global · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Heather L BenzFDA Center for Devices and Radiological Health, Silver Spring, MD, USA. heather.benz@fda.hhs.gov.ORCID 0000-0002-6707-9695
Ting-Hsuan Joyce LeeFDA Center for Devices and Radiological Health, Silver Spring, MD, USA.
Jui-Hua TsaiJohns Hopkins University Center of Excellence in Regulatory Science and Innovation, Baltimore, MD, USA.
John F P BridgesJohns Hopkins University Center of Excellence in Regulatory Science and Innovation, Baltimore, MD, USA.
Sara EggersFDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.
Megan MoncurFDA Center for Drug Evaluation and Research, Silver Spring, MD, USA.
Fadia T ShayaUniversity of Maryland Center of Excellence in Regulatory Science and Innovation, Baltimore, MD, USA.
Ira ShoulsonGeorgetown University Center of Excellence in Regulatory Science and Innovation, Washington, DC, USA.
Erica S SpatzYale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation, New Haven, CT, USA.
Leslie WilsonUCSF-Stanford Center of Excellence in Regulatory Science and Innovation, San Francisco, CA, USA.
Anindita SahaFDA Center for Devices and Radiological Health, Silver Spring, MD, USA.

Funding

Yale-Mayo FDA Center for Excellence in Regulatory Science and InnovationU01FD005938 · FDA · YALE UNIVERSITY · PI Joseph Solomon Ross · 2016 to 2026
$25.4M
University of Maryland Center of Excellence in Regulatory Science and InnovationU01FD005946 · FDA · UNIV OF MARYLAND, COLLEGE PARK · PI BENTLEY, WILLIAM E., POLLI, JAMES E · 2016 to 2025
$21.5M
Johns Hopkins Center of Excellence in Regulatory Science and Innovation (JH-CERSI)U01FD005942 · FDA · JOHNS HOPKINS UNIVERSITY · PI ALEXANDER, G. CALEB · 2016 to 2025
$15.5M
UCSF-Stanford Center of Excellence in Regulatory Science and InnovationU01FD004979 · FDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALTMAN, RUSS BIAGIO, GIACOMINI, KATHLEEN M · 2014 to 2016
$5.4M
Georgetown University Center of Excellence in Regulatory Science and Innovation (CERSI)U01FD004319 · FDA · GEORGETOWN UNIVERSITY · PI DRETCHEN, KENNETH L, MADHAVAN, SUBHA · 2011 to 2016
$3.8M
FDA HHS U01FD004319FDA HHS U01FD005938FDA HHS U01FD005942FDA HHS U01FD005946FDA HHS UO1FD004979
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Equipment and SuppliesPatient PreferenceHumansProduct Surveillance, Postmarketing

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.